Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram and tDCS for Learning Enhancement (LESO)
NCT02092974Phase 1Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of citalopram in Dementia and Mild Cognitive Impairment (MCI), sponsored by Charité – Universitätsmedizin Berlin. Started Apr 2014; status: completed.
02
Drugs
citalopram
03
Conditions
DementiaMild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT02092974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092974.